Compositions and methods for modulating the immune system
View Patent ↗A novel class of embryo derived peptides are described (Preimplantation factor) that were generated synthetically and were tested on peripheral blood immune cells and shown to block activated but not basal immunity, inhibiting cell proliferation and creating a T H 2 type cytokine bias, in addition PIF enhance endometrial receptivity by increasing adhesion molecules expression. PIF biological activity appears to be exerted by specific binding to inducible receptors present on the several white cell lineages. PIF peptides, which are immune modulators therefore may have diagnostic non toxic therapeutic applications in improving fertility, reducing pregnancy loss as well may be useful when administered for the treatment of autoimmune diseases and for prevention xenotransplants rejection.
1. A method of treating an immune-related disorder in a subject comprising administering a PIF peptide selected from PIF-1 (15) (SEQ ID NO:13) and PIF-1 (9) (SEQ ID NO:16), wherein said immune-related disorder is selected from Hashimoto's thyroiditis, type 1 (insulin dependent) diabetes, multiple sclerosis, and graft-versus-host disease.
2. The method of claim 1 , wherein said PIF peptide is PIF-1 (15) (SEQ ID NO:13).
3. The method of claim 1 , wherein a therapeutically effective amount of said PIF peptide is administered.
4. The method of claim 3 , wherein said therapeutically effective amount is from about 0.01 mg/kg to about 10 mg/kg.
5. The method of claim 3 , wherein said therapeutically effective amount is from about 0.1 mg/kg to about 1.0 mg/kg.
6. The method of claim 1 wherein said immune-related disorder is graft-versus-host disease.
7. The method of claim 1 wherein said immune-related disorder is type 1 (insulin dependent) diabetes.
8. The method of claim 1 wherein said immune-related disorder is multiple sclerosis.
9. The method of claim 1 wherein said immune-related disorder is Hashimoto's thyroiditis.